Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia

Journal of Lipid Research

Volumn 53, Issue 12, 2012, Pages 2747-2754

  Malhotra, Jyoti ^a   Tonorezos, Emily S ^b   Rozenberg, Marina ^b   Vega, Gloria L ^c   Sklar, Charles A ^b   Chou, Joanne ^b   Moskowitz, Chaya S ^b   Eshelman Kent, Debra A ^d   Janiszewski, Peter ^e   Ross, Robert ^e   Oeffinger, Kevin C ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Cancer; Dyslipidemias; LDL subfractions; Lipids; Lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; ATHEROGENESIS; BODY FAT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILDHOOD CANCER; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; PHENOTYPE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS; YOUNG ADULT;

EID: 84869020792     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P029785     Document Type: Article

References (42)

1. Altekruse, S. F., C. L. Kosary, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, J. Ruhl, N. Howlader, Z. Tatalovich, H. Cho, et al. 2010. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD.
2. Mulrooney, D. A., M. W. Yeazel, T. Kawashima, A. C. Mertens, P. Mitby, M. Stovall, S. S. Donaldson, D. M. Green, C. A. Sklar, L. L. Robison, et al. 2009. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 339: b4606.
3. Armstrong, G. T., Q. Liu, Y. Yasui, J. P. Neglia, W. Leisenring, L. L. Robison, and A. C. Mertens. 2009. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J. Clin. Oncol. 27: 2328-2338.
4. Lamarche, B., A. Tchernof, S. Moorjani, B. Cantin, G. R. Dagenais, P. J. Lupien, and J. P. Despres. 1997. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 95: 69-75.
5. Rosenson, R. S., J. D. Otvos, and D. S. Freedman. 2002. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am. J. Cardiol. 90: 89-94.
6. Austin, M. A., and R. M. Krauss. 1986. Genetic control of low-densi-ty- lipoprotein subclasses. Lancet. 2: 592-595.
7. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willett, and R. M. Krauss. 1988. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260: 1917-1921.
8. St-Pierre, A. C., B. Cantin, G. R. Dagenais, P. Mauriege, P. M. Bernard, J. P. Despres, and B. Lamarche. 2005. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler. Thromb. Vasc. Biol. 25: 553-559.
9. Castelli, W. P., R. J. Garrison, P. W. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 256: 2835-2838.
10. Hamsten, A., G. Walldius, A. Szamosi, G. Dahlen, and U. de Faire. 1986. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation. 73: 1097-1110.
11. Toft-Petersen, A. P., H. H. Tilsted, J. Aaroe, K. Rasmussen, T. Christensen, B. A. Griffin, I. V. Aardestrup, A. Andreasen, and E. B. Schmidt. 2011. Small dense LDL particles-a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study. Lipids Health Dis. 10: 21.
12. Hirano, T., Y. Ito, S. Koba, M. Toyoda, A. Ikejiri, H. Saegusa, J. Yamazaki, and G. Yoshino. 2004. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler. Thromb. Vasc. Biol. 24: 558-563.
13. Watson, T. D., M. J. Caslake, D. J. Freeman, B. A. Griffin, J. Hinnie, C. J. Packard, and J. Shepherd. 1994. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler. Thromb. 14: 902-910.
14. Srinivasan, S. R., J. P. Segrest, A. M. Elkasabany, and G. S. Berenson. 2001. Distribution and correlates of lipoproteins and their subclasses in black and white young adults. The Bogalusa Heart Study. Atherosclerosis. 159: 391-397.
15. Oeffinger, K. C., B. Adams-Huet, R. G. Victor, T. S. Church, P. G. Snell, A. L. Dunn, D. A. Eshelman-Kent, R. Ross, P. M. Janiszewski, A. J. Turoff, et al. 2009. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 27: 3698-3704.
16. Oeffinger, K. C., A. C. Mertens, C. A. Sklar, Y. Yasui, T. Fears, M. Stovall, T. A. Vik, P. D. Inskip, and L. L. Robison. 2003. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 21: 1359-1365.
17. Garmey, E. G., Q. Liu, C. A. Sklar, L. R. Meacham, A. C. Mertens, M. A. Stovall, Y. Yasui, L. L. Robison, and K. C. Oeffinger. 2008. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 26: 4639-4645.
18. Janiszewski, P. M., K. C. Oeffinger, T. S. Church, A. L. Dunn, D. A. Eshelman, R. G. Victor, S. Brooks, A. J. Turoff, E. Sinclair, J. C. Murray, et al. 2007. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 92: 3816-3821.
19. Geenen, M. M., P. J. Bakker, L. C. Kremer, J. J. Kastelein, and F. E. van Leeuwen. 2010. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr. Blood Cancer. 55: 690-697.
20. Tonorezos, E. S., G. L. Vega, C. A. Sklar, J. F. Chou, C. S. Moskowitz, Q. Mo, T. S. Church, R. Ross, P. M. Janiszewski, and K. C. Oeffinger. 2012. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr. Blood Cancer. 58: 31-36.
21. Halonen, P., J. Mattila, T. Ruuska, M. K. Salo, and A. Makipernaa. 2003. Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings. Med. Pediatr. Oncol. 40: 148-154.
22. Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412-419.
23. Chen, J., R. P. Wildman, L. L. Hamm, P. Muntner, K. Reynolds, P. K. Whelton, and J. He. 2004. Association between inflammation and insulin resistance in US nondiabetic adults: results from the Third National Health and Nutrition Examination Survey. Diabetes Care. 27: 2960-2965.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285: 2486-2497.
25. Kulkarni, K. R. 2006. Cholesterol profile measurement by vertical auto profile method. Clin. Lab. Med. 26: 787-802.
26. Kulkarni, K. R., D. W. Garber, M. K. Jones, and J. P. Segrest. 1995. Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J. Lipid Res. 36: 2291-2302.
27. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am. J. Clin. Nutr. 68: 899-917.
28. Fujioka, S., Y. Matsuzawa, K. Tokunaga, and S. Tarui. 1987. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 36: 54-59.
29. Stata Statistical Software: Release 9. 2005. StataCorp., College Station, TX.
30. McNamara, J. R., H. Campos, J. M. Ordovas, J. Peterson, P. W. Wilson, and E. J. Schaefer. 1987. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis. 7: 483-490.
31. Link, K., C. Moell, S. Garwicz, E. Cavallin-Stahl, J. Bjork, U. Thilen, B. Ahren, and E. M. Erfurth. 2004. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J. Clin. Endocrinol. Metab. 89: 5003-5012.
32. Bowers, D. C., Y. Liu, W. Leisenring, E. McNeil, M. Stovall, J. G. Gurney, L. L. Robison, R. J. Packer, and K. C. Oeffinger. 2006. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 24: 5277-5282.
33. Kostapanos, M. S., H. J. Milionis, K. G. Lagos, C. B. Rizos, A. D. Tselepis, and M. S. Elisaf. 2008. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. Eur. J. Pharmacol. 590: 327-332.
34. Superko, H. R., K. K. Berneis, P. T. Williams, M. Rizzo, and P. D. Wood. 2005. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Am. J. Cardiol. 96: 1266-1272.
35. Siri-Tarino, P. W., P. T. Williams, H. S. Fernstrom, R. S. Rawlings, and R. M. Krauss. 2009. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity (Silver Spring). 17: 1768-1775.
36. Siviero-Miachon, A. A., A. M. Spinola-Castro, and G. Guerra-Junior. 2009. Adiposity in childhood cancer survivors: insights into obesity physiopathology. Arq. Bras. Endocrinol. Metabol. 53: 190-200.
37. Nieves, D. J., M. Cnop, B. Retzlaff, C. E. Walden, J. D. Brunzell, R. H. Knopp, and S. E. Kahn. 2003. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 52: 172-179.
38. Tchernof, A., B. Lamarche, D. Prud'Homme, A. Nadeau, S. Moorjani, F. Labrie, P. J. Lupien, and J. P. Despres. 1996. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 19: 629-637.
39. Bergman, R. N., and S. D. Mittelman. 1998. Central role of the adipocyte in insulin resistance. J. Basic Clin. Physiol. Pharmacol. 9: 205-221.
40. Stan, S., E. Levy, E. E. Delvin, J. A. Hanley, B. Lamarche, J. O'Loughlin, G. Paradis, and M. Lambert. 2005. Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors. Clin. Chem. 51: 1192-1200.
41. Tsimihodimos, V., I. Gazi, C. Kostara, A. D. Tselepis, and M. Elisaf. 2007. Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles. Lipids. 42: 403-409.
42. Hanak, V., J. Munoz, J. Teague, A. Stanley, Jr., and V. Bittner. 2004. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am. J. Cardiol. 94: 219-222.